trabeculoplastika

Trabeculoplastika is a minimally invasive surgical procedure used to treat open-angle glaucoma, a condition characterized by increased pressure within the eye. The procedure involves the injection of a medication into the trabecular meshwork, a network of tiny channels located at the back of the eye. This medication, typically a corticosteroid, helps to reduce the resistance of the trabecular meshwork, thereby lowering intraocular pressure.

The procedure is performed under local anesthesia and typically takes about 10-15 minutes. It is considered a safe and effective alternative to traditional glaucoma surgeries, as it does not require the creation of a surgical wound or the use of an implant. However, it may not be suitable for all patients, particularly those with certain types of glaucoma or those who have had previous eye surgeries.

Trabeculoplastika is often used as a first-line treatment for open-angle glaucoma, especially in patients who are not suitable for or do not wish to undergo traditional glaucoma surgeries. It is also used in cases where the pressure-lowering effect of medication alone is insufficient. The procedure is generally well-tolerated, with most patients experiencing minimal discomfort and no significant side effects. However, as with any surgical procedure, there is a risk of complications, such as infection or bleeding, although these are relatively rare.

The long-term effectiveness of trabeculoplastika varies among patients. Some may experience a significant reduction in intraocular pressure, while others may require additional treatments. Regular follow-up appointments are essential to monitor the procedure's effectiveness and adjust treatment as needed.